Font Size: a A A
Keyword [Dapagliflozin]
Result: 41 - 60 | Page: 3 of 8
41. Clinical Observation On The Treatment Of Refractory Type 2 Diabetes Mellitus With Depagliflozin
42. Observation Of The Clinical Effect Of Dapagliflozin Combined With Insulin In The Treatment Of Type 2 Diabetes With Hyperuricemia
43. The Effect Of Dapagliflozin On Blood Glucose Fluctuation In Type 2 Diabetes Patients With Substandard Blood Glucose
44. The Randomized Controlled Trial Of Additional Use With Dapagliflozin Or Saxaglipin In T2DM Patients With Poorly Controlled Blood Glucose By Using Metformin Alone
45. Clinical Observation Of Dapagliflozin Combined With Liraglutide In The Treatment Of Overweight Type 2 Diabetes Mellitus
46. The Effect And Mechanism Of PHLPP1 And Dapagliflozin In Diabetic Cardiomyopathy
47. The Effect And Mechanism Of Dapagliflozin And MST1 In Diabetic Cardiomyopathy
48. Heart Failure Blood Pressure Management And Pharmacoeconomics Research
49. Effects Of Dapagliflozin On Non-alcoholic Fatty Liver Disease In Patients With Type 2 Diabetes
50. The Protective Effects And Mechanisms Of Dapagliflozin On Kidney Injury In New-onset Type 2 Diabetes Mellitus
51. The Study About Effect And Mechanism Of Liraglutide And Dapagliflozin On Cardiac Function In Type 2 Diabetic Patients
52. The Effect Of Dapagliflozin On Bone Metabolism Markers With Type 2 Diabetes
53. Cost-Utility Analysis Of Dapagliflozin Versus Saxagliptin Treatment As Monotherapy Or Combination Therapy As Add-on To Metformin For Treating Type 2 Diabetes Mellitus
54. The Efficacy Of Liraglutide And Dapagliflozin In T2DM Early Diabetic Nephropathy
55. Effect Of Dapagliflozin On Related Risk Factors Of Type 2 Diabetic Nephropathy
56. Observation Of The Clinical Effect Of Dapagliflozin Combined With Bifidobacterium Tetragenous Viable Bacteria Tablets In The Treatment Of Overweight And Obesity Type 2 Diabetes
57. Dapagliflozin Improves The Dysfunction Of Human Umbilical Vein Endothelial Cells By Inhibiting SGLT-2 To Down-regulate Autophagy Induced By High Glucose/high Fat
58. Dapagliflozin Functions On Regulating Oxidative Stress In Diabetic Kidney Disease Through Regulating CX3CL1
59. A Cross-control Study Of Insulin Combined With Dapagliflozin Or Acarbose In T1DM
60. Study On The Clinical Efficacy Of Daglitazine In The Treatment Of Type 2 Diabetic Patients With Different Degrees Of Proteinuria
  <<First  <Prev  Next>  Last>>  Jump to